Naučne publikacije akademskog osoblja

NAPOMENA

Za tačnost unetih podataka o publikacijama, naučnim i umetničkim referencama odgovorni su autori.
Datum kreiranja: 11.04.2018.

Irena Conić

Dodatne informacije

  • Lični podaci

  • Datum rođenja: 20.05.1979.
  • Mesto rođenja: Niš
  • Obrazovanje

  • Fakultet: Medicinski
  • Odsek / Grupa / Smer: Medicina
  • Godina diplomiranja: 2004.
  • Spisak publikacija

  • Radovi u časopisima sa IMPACT faktorom:

    1. Conic INedovic B, Stojnev S, Todorovska I, Dimitrijevic A, Krstic M, Djordjevic I, Djordjevic B. Bevacizumab with Chemotherapy as a First-Line Treatment for Advanced Ovarian Cancer in a Serbian Cohort. Medicina (Kaunas) 2022;58(5):607. IF 2 2.948   IF5 2.985 (M22).

    2. Tosic Golubovic S, Binic I, Krtinic D, Djordjevic V, Conic IGugleta U, Andjelkovic Apostolovic M, Stanojevic M,  Kostic J.  Risk Factors and Predictive Value of Depression and Anxiety in Cervical Cancer Patients. Medicina (Kaunas) 2022;58(4):507. IF2 2.948 IF5 2.985 (M22).

    3.  Krstic M , Stojnev S, Petkovic I, Conic I, ZujoviC J, Milosevic V. Pathomorphological and clinical features of diffuse large B-cell lymphoma in Southeastern Serbia – seven-year experience at a tertiary center. JBUON 2021; 26(6): 2536-43. IF3 2.533 IF5 1.987 (M23).

    4. Stojnev S, Krstić M, Čukuranović Kokoris J, Conić I, Petković I, Ilić S, Milosević-Stevanović J, Janković Veličković L. Prognostic Impact of Canonical TGF-β Signaling in Urothelial Bladder Cancer. Medicina 2019; 55(6):302. IF5: 1.572 (M22).

    5. Conic I, Stanojevic Z, Jankovic Velickovic Lj, Stojnev S, Ristic Petrovic A, Krstic M, Stanojevic M, Bogdanović D, Stefanovic V. Epithelial ovarian cancer with CD117 phenotype is highly aggressive and resistant to chemotherapy. J Obstet Gynaecol Res 2015; Oct;41(10):1630-7.    IF5:1.057 (M23)

    6. Damnjanovic I,  Kocic G, Najman S, Stojanovic S, Stojanovic D, Veljkovic A, Conic I, Langerholc T, Pesic S. Chemopreventive potential of alpha lipoic acid in the treatment of culture of colon and cervix cancer cell lines. Bratisl Lek Listy 2014; 115: 611-6. IF5:. 0.406 (M23)

    7. Stojnev S, Ristic-Petrovic A, Jankovic Velickovic Lj, Krstic M, Bogdanovic D, Throng Khanh D, Ristic A, Conic I, Stefanovic V. Prognostic significance of mucin expression in urothelial bladder cancer. Int J Clin Exp Pathol 2014;7:4945-58.  IF5: 2.001 (M22)

    8. Conic I, Miljkovic S, Tosic-Golubovic S, Stanojevic Z, Milenkovic D, Djordjevic B, Damnjanovic I, Visnjic M, Antic S, Stefanovic V. Anxiety levels related to the type of therapy for cervical cancer. Central European Journal of Medicine 2012; 7: 490-6. IF5:0.312 (M23) 

    9. Djordjevic B, Stojanovic S, Conic I, Lj.Jankovic-Velickovic, Vukomanovic P, Zivadinovic R, Vukadinovic M. Current approach to epithelial ovarian cancer        based on the concept of cancer stem cells. Journal of BUON 2012; 17: 627-36. IF5: 0.653 (M23)

    10. Conić I, Dimov I, Tasić-Dimov D, Đorđević B, Stefanović V. Ovarian epithelial cancer stem cells. TheScientificWorldJOURNAL 2011;11: 1243-69. IF5:1.603 (M21)

    11. Dimov I, Tasić-Dimov D, Conić I, Stefanovic V. Glioblastoma multiforme stem cells. TheScientificWorldJOURNAL 2011;11: 930-58. IF5:1.603 (M21)


     

  • Radovi u ostalim časopisima:


      1. Conić I, Stojnev S, Dimitrijević A, Janković-Veličković Lj, Djordjević B, Djordjević I, Pejčić I, Vrbić S. Clinical significance of CD44 expression in serous ovarian cancer. Acta Medica Medianae 2020; 59(4): 26-33. (M52)

      2. Stojnev S, Ristić A, Krstić M, Ristić-Petrović A, Conić I, Petković I, Milenković J, Janković Veličković Lj. Expression of epigenetic silencer EZH2 in early invasive pT1 urothelial bladder cancer. Acta Medica Medianae 2018; 57(3):48-54. (M51)

      3. Pejčić I, Petković I, Cvetanović A, Conić I. Single Center Experience Study with Pembrolizumab in Patients with BRAF Mutant Negative Metastatic Melanoma. Acta facultatis medicae Naissensis 2018; 35(4):267-272. (M51)

      4. Damnjanović I, Veličković-Radovanović R, Kocić R, Zlatković-Guberinić S, Sokolović D, Djindjić N, Conić I. Uticaj beta blokatora na insulinsku rezistenciju kod pacijenata sa dijabetes melitusom tip 2. Acta Medica Medianae 2011; 50(4). (M52)

      5. Damnjanović I, Kitić D, Zlatković-Guberinić S, Milosavljević J, Conić I. Savremeni aspekti upotrebe Valerianae officinalis. Acta Medica Medianae 2010; 49(3):65-70. (M52)

      6. Damnjanović I, Veličković-Radovanović R, Catić-Đorđević A, Kocić R, Ćirić V, Conić I, Bjelaković Lj. Farmakokinetičko i farmakodinamičko modeliranje bazalnih insulina i analoga. Acta Medica Medianae 2009; 48(1):15-19. (M52)

      7. Conić I, Stanojević Z, Dedović I, Lilić G. Anksioznost i depresivnost kod bolesnica sa karcinomom grlića materice pre operativnog lečenja. Acta Medica Medianae 2008; 47(2):49-53. (M52)



     

  • Radovi na naučnim skupovima međunarodnog značaja:

    1. Conic I, Stojnev S, Jankovic Velickovic Lj, Djordjevic B, Dimitrijevic A, Miljan K, Ristic Petrovic A, Djordjevic I, Krtinic D. Sox 2 expression in ovarian serous epithelial cancer. ESGO SoA 2020 Conference Abstract. International Journal of Gynecological Cancer. December 2020 Vol 30 (Suppl 4): A87. (M34)

    2. Conic I, Ristic L, Kocic R, Stojev S, Krtinic D. Pulmonary Thromboembolism in Patients with Coronavirus Disease and Chronic Renal Failure. Abstract book: 444. The First World Conference Fighting COVID-19 Pandemic Health Challenges. March, 26-28, 2022, Belgrade, Serbia.(M34)

    3. Stojnev S, Krstic M, Ristic A, Petkovic I, Conic I, Ristic-Petrovic A,  Todorovic J, Mladenovic M. Association of STAT3 expression and enhanced angiogenesis in primary extranodal diffuse large B cell lymphoma. Virchows Archiv 2021; 479 (Suppl 1): S116. The 33rd Congress of Pathology, 29 – 31 August 2021, virtual. https://doi.org/10.1007/s00428-021-03157-8. IF: 2.906 (M34)

    4. Stojnev S, Krstic M, Ristic-Petrovic A, Jankovic Velickovic L, Conic I, Todorovic J, Mladenovic M, Ristic A. Decreased FAS expression predicts poor survival in muscle-invasive bladder cancer. Virchows Archiv 2021; 479 (Suppl 1): S177. The 33rd Congress of Pathology, 29 – 31 August 2021, virtual. https://doi.org/10.1007/s00428-021-03157-8. IF: 2.906 (M34)

    5. Stojnev S,  Krstic M, Ristic-Petrovic A, Jankovic-VelickovicLj, Conic I,  Velickov A, Potic-Floranovic M, Mladenovic M, Todorovic J. Expression of death receptors DR4 and DR5 in non-muscle-invasive bladder cancer. Virchows Arch 2018; 473 (Suppl 1): S185. The 30th European Congress of Pathology, 8 – 12 September 2018, Bilbao, Spain. (M34)

    6. Ristic-Petrovic A, Stojnev S, Stokanovic D, Potic-Floranovic M, Velickov A, Krstic M,  Conic I, Jankovic-VelickovicLj. An immunohistochemical analysis of angiogenesis in bladder cancer occurring in settlements linked with Balkan endemic nephropathy. Virchows Arch 2018; 473 (Suppl 1): S185. The 30th European Congress of Pathology, 8 – 12 September 2018, Bilbao, Spain. (M34)

    7. Conic I, Stojnev S, Jankovic-VelickovicLj,  Djordjevic B,  Djordjevic I,  Ristic-Petrovic A,  Krtinic D,  Krstic M. The role of CD44 in ovarian cancer. Int J Gynecol Cancer 2017; 27 (Suppl 4): 1928. (M34)

    8. Krtinić D, Živadinović R, Jović Z, Pavlović V, Pavlović S, Stokanović D, Nedin Ranković G, Todorovska I, Stojanović V, Bojić D, Conić I, Cvetanović A, Antić V, Lilić G, Petrić A. Further diagnostic and therapeutic management of patients with ASC cytological PAP findings.  Int J Gynecol Cancer 2017; 27 (Suppl 4): 803. (M34)

    9. Stojnev S, Krstic M, Ristic A, Todorovic J, Mladenovic M, Ristic-Petrovic A, Conic I, JankovicVelickovicLj. Correlation between expression of epigenetic silencer EZH2 and Claudin-4 and their prognostic value in urothelial bladder cancer - immunohistochemical study. Virchows Arch 2017; 471 (Suppl 1):S29. OFP-09-012. ISSN: 0945-6317 (Print) 1432-2307 (Online). The 29th European Congress of Pathology, 2 – 6 September 2017, RAI Amsterdam, The Netherlands. (M34)

    10. Stojnev S, Krstic M, Mladenovic M, Todorovic J, Ristic-Petrovic A, Conic I, Stojanovic S, Jankovic Velickovic Lj. Prognostic impact of p63 and Beta-catenin coexpression in urothelial bladder cancer. Virchows Arch 2016; 469 (Suppl 1):S15. OFP-05-011. The XXXI International Congress of International Academy of Pathology and 28th Congress of the European Society of Pathology, September 25-29th 2016, Cologne, Germany. (M34)

    11. Ristic-Petrovic A, Stojnev S, Stokanovic D, Conic I, Krstic M, Stojanovic S, Zivkovic N, Dencic T, Zivkovic V, Jankovic Velickovic Lj. Predictive impact of angiogenesis and hypoxia related markers in urothelial bladder cancer. Virchows Arch 2016; 469 (Suppl 1):S15-S16. OFP-05-012.  The XXXI International Congress of International Academy of Pathology and 28th Congress of the European Society of Pathology, September 25-29th 2016, Cologne, Germany. (M34)

    12. Stojnev S, Ristic-Petrovic А, Krstic М, Conic I, Jankovic Velickovic Lj. The expression of MUC2 and MUC6 predicts survival in urothelial bladder cancer. Virchows Arch 2015; 467(Suppl 1):S21–S22. ISSN: 0945-6317 (Print) 1432-2307 (Online). The 27th European Congress of Pathology (ECP 2015), September 5-9th 2015, Belgrade, Serbia. (M34)

    13. Conić I, Lilić R, Stanojević Z, Stojnev S. Efikasnost pregabalina u kombinaciji sa opijatima u lečenju neuropatskog bola- prikaz slučaja. Udruženje za istraživanje i tretman bola Srbije (UITBS) I Deutsche Schmerzgesellschaft e.V. (DGSS). April 2015. (M34)

    14. Tosic Golubovic S , Zikic O, Conic I, Nikolic G, Sibinovic V. Anxiety and Depression Among Women With Cervical Cancer. Psycho-Oncology 2014; 23 (Suppl. 3): 338-417. (M34)

    15. Conic I, Spasic Ivanov D, Zdravkovic D, Dimic D, Antic D. Abstract book. Značaj blagovremenog uvođenja insulinske terapije kod pacijenata sa dijabetesom tip 2. Drugi kongres endokrinologa Srbije sa međunarodnim učešćem, Beograd 2010, 64:A48. (M34)

    16. Conic I, Stanojevic Z. The influence of certain typer of cervical cancer therapies on depressiveness of patients. Abstract book. V congress of internal medicine for the south-eastern Europe, Belgrade, Serbia 2009; 49:P90. (M34)

    17. Conic I, Zdravkovic D, Spasic-Ivanov S, Milenkovic D, Dimic D, Stanojevic Z, Antic S. Abstract book. Da li se kod bolesnika sa dijabetesom tip 2 kasni sa uvodjenjem insulinske terapije? 6. Srpski kongres o šećernoj bolesti sa međunarodnim učešćem, Beograd 2009; 103:PP66. (M34)

  • Radovi na domaćim naučnim skupovima:

    1. Stojanović D, Petrović A, Conić I. Radioterapija dojke I regionalnih limfnih žlezda-savremene smernice I kontraverze. Nacionalni simpozijum. Zbornik sažetaka. 17-18. Januar 2020, Vranje, Srbija.

    2. Stojnev S, Conić I. Prognostički značaj ekspresije EZH2 u rano invazivnom T1 urotelnom karcinomu mokraćne bešike visokog histološkog gradusa. Abstract book: 42.The first national congress of the urological section of Serbian medical association and regional joint meeting September, 28-30th, 2017, Belgrade, Serbia.

    3. Conić I, Stanojević Z, Filipović S, Pejčić I, Stojnev S, Vrbić S. Uticaj vrste terapije karcinoma grlića materice na kvalitet života bolesnica. 51. Kancerološka nedelja. Beograd 2014, 46: O16. (M64)

    4. Conić I, Stanojević Z, Filipović S, Stojnev S, Pejčić I, Vrbić S. Ekspresija CD44, CD117, Sox2 i Oct 3/4kod karcinoma jajnika. 50. Kancerološka nedelja. Beograd 2013, 27:O3. (M64)

    5. Conic I, Stanojevic Z, Potić Zečević N, Pejčić I, Vrbić S. Abstract book. Anxiety levels related to the type of therapy for cervical cancer. 49. Kancerološka nedelja. Beograd 2012, 74:P6. (M64)

    6. Conić I, Ćirić V. Sclerodermia systemica-acrosclerosis. Abstract book. 19th IMSSC, Istanbul-Turkie 2004; 56. (M64)

    7. Ćirić V, Conić I, Stefanović J. G-cell, gastritis types and gastrin level in patients with pernicious anaemia. Abstract book. 19th IMSSC, Istanbul-Turkie 2004; 49. (M64)

    8. Conić I, Ćirić V, Cekić O. Surgical healing of melanoma. Abstract book. 45th Congress of Medicine and Stomatology students of Serbia and Montenegro, Budva 2004; 343. (M64)

    9. Conić I, Jović V. The influence of different kinds of loads on blood pressure and heart rate at athletes. Abstract book. 45th Congress of Medicine and Stomatology students of Serbia and Montenegro, Budva 2004; 368. (M64)

    10. Ćirić V, Conić I, Babović M, Milićević D. G-cell, gastritis types and gastrin level in patients with pernicious anemia. Abstract book. 45th Congress of Medicine and Stomatology students of Serbia and Montenegro, Budva 2004; 290. (M64)

    11. Conić I, Ćirić V. Diagnosis and treatment of melanoma. Abstract book. 27th International medical students’s scientific congress, Ohrid-Macedonia 2004; 341. (M64)

    12. Ćirić V, Conić I, Stefanović J. 5’-nukleotidase activity in experimental iron. overload. Abstract book. 27th International medical students’s scientific congress, Ohrid-Macedonia 2004; 065. (M64)

    13. Conić I. The influence of different kinds of loads on blood pressure and heart rate and lipids in athletes. Abstract book. 15th European students’ conference for future doctors and young scientists, Berlin 2004; 366-7. (M64)

    14. Conić I, Stanojević M, Ranković B. Pyoderma gangrenosum. Abstract book. 44th Congress of Medicine and Stomatology students of Serbia and Montenegro, Bečići 2003; E-15. (M64)

    15. Ranković B, Conić I, Cvetanović V, Živković M. The presence of iron in tissue in some preneoplastical changes and neoplasma. Abstract book. 44 Congress of medicine and Stomatology students of Serbia and Montenegro, Bečići 2003;   V-91. (M64)


Poslednji put izmenjeno nedelja, 11 septembar 2022 23:41